Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Octacosane-d58

Octacosane-d58 is the deuterium labeled Octacosane[1]. Octacosane is an endogenous metabolite with antibacterial activity. Octacosane shows high cytotoxicity against murine melanoma B16F10-Nex2 cells besides inducing protection against a grafted subcutaneous melanoma. Octacosane has the larvicidal activity against mosquito Culex quinquefasciatus with the LC50 concentration of 7.2 mg/l[2][3][4].

Product Specifications

CAS Number

16416-33-4

Product Name Alternative

N-Octacosane-d58; NSC 5549-d58

UNSPSC

12352211

Hazard Statement

H302, H315, H319, H335

Target

Bacterial; Endogenous Metabolite

Type

Isotope-Labeled Compounds

Related Pathways

Anti-infection; Metabolic Enzyme/Protease

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Cancer

Purity

99.05

Solubility

DMSO : < 1 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H]

Molecular Formula

C28D58

Molecular Weight

453.12

Precautions

H302, H315, H319, H335

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.|[2]Carlos R Figueiredo, et al. Pyrostegia venusta heptane extract containing saturated aliphatic hydrocarbons induces apoptosis on B16F10-Nex2 melanoma cells and displays antitumor activity in vivo. Pharmacogn Mag. 2014 Apr;10 (Suppl 2) :S363-76. |[3]S Rajkumar, et al. Mosquitocidal activities of octacosane from Moschosma polystachyum Linn (lamiaceae) . J Ethnopharmacol. 2004 Jan;90 (1) :87-9.|[4]Sameh S M Soliman, et al. Effective targeting of breast cancer cells (MCF7) via novel biogenic synthesis of gold nanoparticles using cancer-derived metabolites. PLoS One. 2020 Oct 6;15 (10) :e0240156.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Isotope-Labeled Compounds

Clinical Information

No Development Reported

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Eph receptor B4 (EPHB4) Human Gene Knockout Kit (CRISPR)
KN208559LP 1 Kit

Eph receptor B4 (EPHB4) Human Gene Knockout Kit (CRISPR)

Sign In for Pricing
View Details
SERCA2 ATPase Antibody
R30810 100 µg

SERCA2 ATPase Antibody

Sign In for Pricing
View Details
HFE Human Gene Knockout Kit (CRISPR)
KN217447LP 1 Kit

HFE Human Gene Knockout Kit (CRISPR)

Sign In for Pricing
View Details
Ddt (NM_010027) Mouse Tagged ORF Clone
MG200552 10 µg

Ddt (NM_010027) Mouse Tagged ORF Clone

Sign In for Pricing
View Details
Human GLT6D1 activation kit by CRISPRa
GA117749 1 Kit

Human GLT6D1 activation kit by CRISPRa

Sign In for Pricing
View Details
MDA5 (IFIH1) Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI8C10]
TA803667BM 100 µL

MDA5 (IFIH1) Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI8C10]

Sign In for Pricing
View Details